Personalized menopause care with FDA-approved hormonal and non-hormonal options. Async chat with clinicians, medications shipped to your door.
Optimization-focused telehealth offering HRT, TRT, and peptide therapy. Comprehensive lab work upfront.
Cash-pay menopause telehealth offering bioidentical HRT (compounded and FDA-approved). Subscription with medications shipped monthly.
Cash-pay menopause telehealth with FDA-approved HRT delivered monthly. Co-founded by Healthline ex-CEO.
Whole-person weight loss with GLP-1 medication plus behavioral coaching. One of the larger GLP-1 telehealth programs.
Multi-medication telehealth with strong compounded GLP-1 offering for women. Also offers HRT, peptides, and wellness add-ons.
GLP-1 weight loss telehealth with compounded semaglutide and tirzepatide. Direct-to-consumer, async prescribing model.
Hims & Hers' weight loss division offering compounded GLP-1s plus FDA-approved options. Among the most affordable starting prices.
App-based menopause care with clinician access and lifestyle coaching. Originally UK-based, expanding US presence.
Direct-to-consumer menopause subscription with FDA-approved HRT, optional coaching, and a focus on the perimenopause-to-postmenopause transition.
Menopause-focused brand expanded in 2024 from OTC products to telehealth HRT prescribing.
App + coaching menopause platform with a focus on behavioral support. Stasis is the app product; US clinical service available in select states.
New 2024 entrant focused on women-led GLP-1 prescribing with PCOS comorbidity awareness.
Doctor-led GLP-1 weight loss program. Offers compounded semaglutide/tirzepatide and FDA-approved Wegovy/Zepbound for eligible patients.
GLP-1-focused DTC platform offering compounded semaglutide and tirzepatide with monthly delivery.
Hormone testing and replacement platform expanded to women’s HRT in 2024. At-home lab kits + clinician follow-up.
Direct-to-clinician marketplace where users find providers willing to prescribe compounded semaglutide.
Hers launched menopause vertical in 2024. Async-first HRT with focus on affordability and speed.
Women-led birth control and women's health telehealth that includes PCOS-relevant care (hormonal birth control, spironolactone, metformin where appropriate).
Async PCOS prescribing for acne, hirsutism, and irregular cycles. Affordable monthly plans.